1
|
Mishev AL, Kodaira S, Kitamura H, Ploc O, Ambrožová I, Tolochek RV, Kartsev IS, Shurshakov VA, Artamonov AA, Inozemtsev KO. Radiation environment in high-altitude Antarctic plateau: Recent measurements and model studies. Sci Total Environ 2023:164304. [PMID: 37230348 DOI: 10.1016/j.scitotenv.2023.164304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Revised: 05/03/2023] [Accepted: 05/16/2023] [Indexed: 05/27/2023]
Abstract
Polar regions are the most exposed to secondary particles and radiation produced by primary cosmic rays in the atmosphere, because naturally they are with marginal geomagnetic shielding. In addition, the secondary particle flux contributing to the complex radiation field is enhanced at high-mountain altitudes compared to sea level because of the reduced atmospheric attenuation. At present, there are very few systematic experimental measurements of environmental dose at high southern latitudes, specifically at high-altitude region. Here, we report a campaign of measurements with different devices, that is passive and Liulin-type dosimeters, of the radiation background at high-mountain Antarctic station Vostok (3488 m above sea level, 78° 27' S; 106° 50' E). We compare the measurements with a Monte Carlo-based model for the propagation of the cosmic rays through the atmosphere and assessment of the radiation field in the atmosphere. We employed the model to estimate the radiation dose at Vostok station during the ground-level enhancement at 28 October 2021. As in previous studies by other teams, we show that the annual dose equivalent at high-altitude Antarctic facilities can significantly exceed the limit of 1 mSv established for the general population by the ICRP.
Collapse
Affiliation(s)
- A L Mishev
- Space Physics and Astronomy Research Unit, University of Oulu, Finland; Sodankylä Geophysical Observatory, University of Oulu, Finland.
| | - S Kodaira
- Radiation Measurement Research Group, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - H Kitamura
- Radiation Measurement Research Group, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - O Ploc
- Nuclear Physics Institute of the Czech Academy of Sciences, Hlavní 130, Řež 250 68, Czech Republic
| | - I Ambrožová
- Nuclear Physics Institute of the Czech Academy of Sciences, Hlavní 130, Řež 250 68, Czech Republic
| | - R V Tolochek
- Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation; P.N.Lebedev Physical Institute of the Russian Academy of Sciences (LPI RAS), 53 Leninskiy Prospekt, Moscow 119991, Russian Federation
| | - I S Kartsev
- Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation; LLC "SNIIP-Plus", 5(1) Raspletina, Moscow 123060, Russian Federation
| | - V A Shurshakov
- Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation
| | - A A Artamonov
- Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation
| | - K O Inozemtsev
- Institute of Biomedical Problems of the Russian Academy of Sciences (IBMP RAS), 76A Khoroshevskoye shosse, Moscow 123007, Russian Federation
| |
Collapse
|
2
|
Hagiwara K, Kitamura H, Tsuchiya Y, Mizoshiri A, Iwabuchi T. 563 CsA-induced hypertrichosis might be caused in part by inhibition of TGF-β2 expression in dermal papilla cells. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.09.579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
3
|
Kanesvaran R, Kikuchi E, Kitamura H, Ku J, Lee L, Lin TP, Nishiyama H, Ng A, Ng J, Poon D, Seo H, Shamaileh R, Spiteri C, Tan E, Tran B, Tsai YS. 150P Use of neoadjuvant chemotherapy for non-metastatic muscle-invasive bladder cancer in Asia-Pacific. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
4
|
Lee L, Kanesvaran R, Kikuchi E, Kitamura H, Ku J, Lin TP, Nishiyama H, Ng A, Ng J, Poon D, Seo H, Shamaileh R, Spiteri C, Tan E, Tran B, Tsai YS. 149P A need for clear definitions and improved management for BCG-unresponsive tumors in Asia-Pacific. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
5
|
Kanesvaran R, Castro E, Wong A, Fizazi K, Chua MLK, Zhu Y, Malhotra H, Miura Y, Lee JL, Chong FLT, Pu YS, Yen CC, Saad M, Lee HJ, Kitamura H, Prabhash K, Zou Q, Curigliano G, Poon E, Choo SP, Peters S, Lim E, Yoshino T, Pentheroudakis G. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer. ESMO Open 2022; 7:100518. [PMID: 35797737 PMCID: PMC9434138 DOI: 10.1016/j.esmoop.2022.100518] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 04/28/2022] [Accepted: 05/22/2022] [Indexed: 11/03/2022] Open
Abstract
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of prostate cancer was published in 2020. It was therefore decided, by both the ESMO and the Singapore Society of Oncology (SSO), to convene a special, virtual guidelines meeting in November 2021 to adapt the ESMO 2020 guidelines to take into account the differences associated with the treatment of prostate cancer in Asia. These guidelines represent the consensus opinions reached by experts in the treatment of patients with prostate cancer representing the oncological societies of China (CSCO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of the current treatment practices and drug access restrictions in the different Asian countries. The latter were discussed when appropriate. The aim is to provide guidance for the optimisation and harmonisation of the management of patients with prostate cancer across the different regions of Asia.
Collapse
Affiliation(s)
- R Kanesvaran
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore.
| | - E Castro
- Department of Medical Oncology, Virgen de la Victoria University Hospital, Institute of Biomedical Research in Málaga, Malaga, Spain
| | - A Wong
- Division of Medical Oncology, National University Cancer Institute, Singapore, Singapore
| | - K Fizazi
- Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France
| | - M L K Chua
- Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore
| | - Y Zhu
- Department of Urology, Fudan University, Shanghai Cancer Center, Shanghai, China
| | - H Malhotra
- Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Mahatma Gandhi University of Medical Sciences & Technology, Jaipur, India
| | - Y Miura
- Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan
| | - J L Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - F L T Chong
- Department of Radiotherapy and Oncology, Sabah Women and Children's Hospital, Kota Kinabalu, Malaysia
| | - Y-S Pu
- Department of Urology, National Taiwan University Hospital, Taipei, Taiwan
| | - C-C Yen
- Division of Clinical Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan
| | - M Saad
- Department of Clinical Oncology, University of Malaya Medical Centre, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - H J Lee
- Department of Medical Oncology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, South Korea
| | - H Kitamura
- Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan
| | - K Prabhash
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
| | - Q Zou
- Department of Urology, Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
| | - G Curigliano
- European Institute of Oncology, IRCCS and University of Milano, Milan, Italy
| | - E Poon
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore
| | - S P Choo
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Medical Oncology, Curie Oncology, Singapore, Singapore
| | - S Peters
- Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland
| | - E Lim
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore
| | - T Yoshino
- Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| | | |
Collapse
|
6
|
Kitamura H, Ueshima M, Back S, Sutthasil N, Sakanakura H, Ishigaki T, Yamada M. Impact of diatomite addition on lead immobilization in air pollution control residues from a municipal solid waste incinerator. Environ Sci Pollut Res Int 2022; 29:21232-21243. [PMID: 34751883 PMCID: PMC8930887 DOI: 10.1007/s11356-021-17349-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Accepted: 10/30/2021] [Indexed: 06/13/2023]
Abstract
Air pollution control (APC) residues, which are known to be the byproducts of incineration treatment, exhibit a high leaching potential of toxic metals. Calcium silicate hydrate (C-S-H), which is a major hydration product of hardened cement and immobilizes toxic metal, can be formed by the reaction of Ca with pozzolanic Si in a highly alkaline environment. Toxic metals might be immobilized by the addition of pozzolanic material to APC residues (instead of using cement), which is a Ca source and provides an alkaline condition. In this study, diatomite, which mainly comprises amorphous silica (SiO2·nH2O), was investigated as a pozzolanic material for Pb immobilization in APC residues obtained from a municipal solid waste incinerator. APC residues were cured with and without the addition of diatomite at different temperatures. When diatomite was added to APC residues, pozzolanic phases such as C-S-H gel were formed via the consumption of Ca(OH)2 and CaClOH. Compared to APC residues cured without diatomite, the leaching of Pb decreased by 99% for APC residues cured for 14 days with 10% diatomite at 70 °C. The results of sequential chemical extraction showed that water-soluble Pb in APC residues was reduced from 10.3% to nearly zero by the pozzolanic reaction. Consequently, the leaching amount of Pb dropped below 0.3 mg/L (Japanese criteria for landfill disposal). Overall, these experiments provide promising results regarding the possibility of using diatomite for pretreating APC residues.
Collapse
Affiliation(s)
- Hiroki Kitamura
- Material Cycles Division, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba, Ibaraki, 305-8506, Japan.
| | - Masato Ueshima
- R&D Center, Yoshino Gypsum Co., LTD, 2-1-1 Kohoku, Adachi-ku, Tokyo, 123-0872, Japan
| | - Seungki Back
- Material Cycles Division, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba, Ibaraki, 305-8506, Japan
| | - Noppharit Sutthasil
- Material Cycles Division, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba, Ibaraki, 305-8506, Japan
| | - Hirofumi Sakanakura
- Material Cycles Division, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba, Ibaraki, 305-8506, Japan
| | - Tomonori Ishigaki
- Material Cycles Division, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba, Ibaraki, 305-8506, Japan
| | - Masato Yamada
- Material Cycles Division, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba, Ibaraki, 305-8506, Japan
| |
Collapse
|
7
|
Taoka R, Kobayashi T, Hidaka Y, Abe H, Morita S, Ogawa O, Nishiyama H, Kitamura H, Sugimoto M. Impact of non-muscle invasive bladder cancer treatment history on the efficacy of pembrolizumab for patients with metastatic urothelial carcinoma. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00985-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
8
|
Kanesvaran R, Porta C, Wong A, Powles T, Ng QS, Schmidinger M, Ye D, Malhotra H, Miura Y, Lee JL, Chong FLT, Pu YS, Yen CC, Saad M, Lee HJ, Kitamura H, Bhattacharyya GS, Curigliano G, Poon E, Choo SP, Peters S, Lim E, Yoshino T, Pentheroudakis G. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma. ESMO Open 2021; 6:100304. [PMID: 34864348 PMCID: PMC8645910 DOI: 10.1016/j.esmoop.2021.100304] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2021] [Revised: 09/22/2021] [Accepted: 10/17/2021] [Indexed: 01/05/2023] Open
Abstract
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of renal cell carcinoma was published in 2019 with an update planned for 2021. It was therefore decided by both the ESMO and the Singapore Society of Oncology (SSO) to convene a special, virtual guidelines meeting in May 2021 to adapt the ESMO 2019 guidelines to take into account the ethnic differences associated with the treatment of renal cell carcinomas in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with renal cell carcinoma representing the oncological societies of China (CSCO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of the current treatment practices and drug access restrictions in the different Asian countries. The latter were discussed when appropriate.
Collapse
Affiliation(s)
- R Kanesvaran
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
| | - C Porta
- Department of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy
| | - A Wong
- Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
| | - T Powles
- Barts Cancer Institute, Queen Mary University, London, UK
| | - Q S Ng
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
| | - M Schmidinger
- Department of Urology I, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
| | - D Ye
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
| | - H Malhotra
- Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Mahatma Gandhi University of Medical Sciences & Technology, Jaipur, India
| | - Y Miura
- Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan
| | - J L Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - F L T Chong
- Department of Radiotherapy and Oncology, Sabah Women and Children's Hospital, Kota Kinabalu, Sabah, Malaysia
| | - Y-S Pu
- Department of Urology, National Taiwan University Hospital, Taipei, Taiwan
| | - C-C Yen
- Division of Clinical Research, Department of Medical Research and Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan
| | - M Saad
- Department of Clinical Oncology, University of Malaya Medical Centre, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
| | - H J Lee
- Department of Medical Oncology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea
| | - H Kitamura
- Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan
| | | | - G Curigliano
- Istituto Europeo di Oncologia, IRCCS and University of Milano, Milan, Italy
| | - E Poon
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
| | - S P Choo
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore; Medical Oncology, Curie Oncology, Singapore, Singapore
| | - S Peters
- Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland
| | - E Lim
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
| | - T Yoshino
- Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| | | |
Collapse
|
9
|
Abstract
Bacterial biofilms, which can be found wherever there is water and a substrate, can cause chronic infections and clogging of industrial flow systems. Despite intensive investigation of the dynamics and rheological properties of biofilms, the impact of their rheological properties on streamer growth remains unknown. We numerically simulated biofilm growth in a pillar-flow and investigated the effects of rheological properties of a filamentous flow-shaped biofilm, called a 'streamer', on its formation by varying the viscoelasticity. The flow-field is assumed to be a Stokes flow and is solved by a boundary element method. A Maxwell model is used for extracellular matrix-mediated streamer growth to express the fluidity of streamer formations. Both high elastic modulus and viscosity are needed for streamer formation, and high viscosity promotes streamer growth at low cell concentrations. Our findings are consistent with experimental observations and can explain the relationship between the cell concentrations and viscosity at which streamers form.
Collapse
Affiliation(s)
- Hiroki Kitamura
- Department of Finemechanics, Tohoku University, Aoba 6-6-01, Sendai, Miyagi, Japan
| | - Toshihiro Omori
- Department of Finemechanics, Tohoku University, Aoba 6-6-01, Sendai, Miyagi, Japan
| | - Takuji Ishikawa
- Department of Finemechanics, Tohoku University, Aoba 6-6-01, Sendai, Miyagi, Japan.,Department of Biomedical Engineering, Tohoku University, Aoba 6-6-01, Sendai, Miyagi, Japan
| |
Collapse
|
10
|
Bai Y, Kitamura H, Gao S, Tian Y, Park N, Park MH, Adachi H, Shibata A, Sato M, Murayama M, Tsuji N. Unique transition of yielding mechanism and unexpected activation of deformation twinning in ultrafine grained Fe-31Mn-3Al-3Si alloy. Sci Rep 2021; 11:15870. [PMID: 34354093 PMCID: PMC8342466 DOI: 10.1038/s41598-021-94800-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Accepted: 07/15/2021] [Indexed: 02/07/2023] Open
Abstract
Tensile mechanical properties of fully recrystallized TWIP steel specimens having various grain sizes (d) ranging from 0.79 μm to 85.6 μm were investigated. It was confirmed that the UFG specimens having the mean grain sizes of 1.5 μm or smaller abnormally showed discontinuous yielding characterized by a clear yield-drop while the specimens having grain sizes larger than 2.4 μm showed normal continuous yielding. In-situ synchrotron radiation XRD showed dislocation density around yield-drop in the UFG specimen quickly increased. ECCI observations revealed the nucleation of deformation twins and stacking faults from grain boundaries in the UFG specimen around yielding. Although it had been conventionally reported that the grain refinement suppresses deformation twinning in FCC metals and alloys, the number density of deformation twins in the 0.79 μm grain-sized specimen was much higher than that in the specimens with grain sizes of 4.5 μm and 15.4 μm. The unusual change of yielding behavior from continuous to discontinuous manner by grain refinement could be understood on the basis of limited number of free dislocations in each ultrafine grain. The results indicated that the scarcity of free dislocations in the recrystallized UFG specimens changed the deformation and twinning mechanisms in the TWIP steel.
Collapse
Affiliation(s)
- Yu Bai
- grid.30055.330000 0000 9247 7930School of Materials Science and Engineering, Dalian University of Technology, No.2 Linggong Road, Ganjingzi District, Dalian, 116024 People’s Republic of China ,grid.258799.80000 0004 0372 2033Department of Materials Science and Engineering, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan ,grid.258799.80000 0004 0372 2033Elements Strategy Initiative for Structural Materials (ESISM), Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Hiroki Kitamura
- grid.258799.80000 0004 0372 2033Department of Materials Science and Engineering, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Si Gao
- grid.258799.80000 0004 0372 2033Department of Materials Science and Engineering, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Yanzhong Tian
- grid.412252.20000 0004 0368 6968Key Laboratory for Anisotropy and Texture of Materials (Ministry of Education), School of Materials Science and Engineering, Northeastern University, Shenyang, 110819 People’s Republic of China
| | - Nokeun Park
- grid.258799.80000 0004 0372 2033Elements Strategy Initiative for Structural Materials (ESISM), Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan ,grid.413028.c0000 0001 0674 4447Department of Materials Science and Engineering, Yeungnam University, Gyeongbuk, 38541 Korea
| | - Myeong-heom Park
- grid.258799.80000 0004 0372 2033Department of Materials Science and Engineering, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan ,grid.258799.80000 0004 0372 2033Elements Strategy Initiative for Structural Materials (ESISM), Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Hiroki Adachi
- grid.266453.00000 0001 0724 9317Department of Materials and Synchrotron Radiation Engineering, Graduate School of Engineering, University of Hyogo, Himeji, 671-2280 Japan
| | - Akinobu Shibata
- grid.258799.80000 0004 0372 2033Department of Materials Science and Engineering, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan ,grid.258799.80000 0004 0372 2033Elements Strategy Initiative for Structural Materials (ESISM), Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan ,grid.21941.3f0000 0001 0789 6880National Institute for Materials Science (NIMS), 1-2-1 Sengen, Tsukuba, 305-0047 Japan
| | - Masugu Sato
- grid.410592.b0000 0001 2170 091XJapan Synchrotron Radiation Research Institute (JASRI), Sayo-gun, Hyogo, 679-5198 Japan
| | - Mitsuhiro Murayama
- grid.177174.30000 0001 2242 4849Institute for Materials Chemistry and Engineering, Kyushu University, Kasuga, Fukuoka, 816-8580 Japan ,grid.438526.e0000 0001 0694 4940Department of Materials Science and Engineering, Virginia Tech, Blacksburg, VA 24061 USA
| | - Nobuhiro Tsuji
- grid.258799.80000 0004 0372 2033Department of Materials Science and Engineering, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan ,grid.258799.80000 0004 0372 2033Elements Strategy Initiative for Structural Materials (ESISM), Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, 606-8501 Japan
| |
Collapse
|
11
|
Inozemtsev K, Kodaira S, Kusumoto T, Kitamura H, Strádi A, Szabó J, Ambrožová I, Shurshakov V. Etched track detector methods for the identification of target nuclear fragments in cosmic radiation and accelerator proton beams. RADIAT MEAS 2021. [DOI: 10.1016/j.radmeas.2020.106505] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
12
|
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, Aburto M, Acosta O, Andrews C, Antin-Ozerkis D, Arce G, Arias M, Avdeev S, Barczyk A, Bascom R, Bazdyrev E, Beirne P, Belloli E, Bergna M, Bergot E, Bhatt N, Blaas S, Bondue B, Bonella F, Britt E, Buch K, Burk J, Cai H, Cantin A, Castillo Villegas D, Cazaux A, Cerri S, Chaaban S, Chaudhuri N, Cottin V, Crestani B, Criner G, Dahlqvist C, Danoff S, Dematte D'Amico J, Dilling D, Elias P, Ettinger N, Falk J, Fernández Pérez E, Gamez-Dubuis A, Giessel G, Gifford A, Glassberg M, Glazer C, Golden J, Gómez Carrera L, Guiot J, Hallowell R, Hayashi H, Hetzel J, Hirani N, Homik L, Hope-Gill B, Hotchkin D, Ichikado K, Ilkovich M, Inoue Y, Izumi S, Jassem E, Jones L, Jouneau S, Kaner R, Kang J, Kawamura T, Kessler R, Kim Y, Kishi K, Kitamura H, Kolb M, Kondoh Y, Kono C, Koschel D, Kreuter M, Kulkarni T, Kus J, Lebargy F, León Jiménez A, Luo Q, Mageto Y, Maher T, Makino S, Marchand-Adam S, Marquette C, Martinez R, Martínez M, Maturana Rozas R, Miyazaki Y, Moiseev S, Molina-Molina M, Morrison L, Morrow L, Moua T, Nambiar A, Nishioka Y, Nunes H, Okamoto M, Oldham J, Otaola M, Padilla M, Park J, Patel N, Pesci A, Piotrowski W, Pitts L, Poonyagariyagorn H, Prasse A, Quadrelli S, Randerath W, Refini R, Reynaud-Gaubert M, Riviere F, Rodríguez Portal J, Rosas I, Rossman M, Safdar Z, Saito T, Sakamoto N, Salinas Fénero M, Sauleda J, Schmidt S, Scholand M, Schwartz M, Shapera S, Shlobin O, Sigal B, Silva Orellana A, Skowasch D, Song J, Stieglitz S, Stone H, Strek M, Suda T, Sugiura H, Takahashi H, Takaya H, Takeuchi T, Thavarajah K, Tolle L, Tomassetti S, Tomii K, Valenzuela C, Vancheri C, Varone F, Veeraraghavan S, Villar A, Weigt S, Wemeau L, Wuyts W, Xu Z, Yakusevich V, Yamada Y, Yamauchi H, Ziora D. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med 2020; 8:453-460. [PMID: 32145830 DOI: 10.1016/s2213-2600(20)30036-9] [Citation(s) in RCA: 263] [Impact Index Per Article: 65.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Revised: 01/06/2020] [Accepted: 01/16/2020] [Indexed: 12/20/2022]
Abstract
BACKGROUND The INBUILD trial investigated the efficacy and safety of nintedanib versus placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF). We aimed to establish the effects of nintedanib in subgroups based on ILD diagnosis. METHODS The INBUILD trial was a randomised, double-blind, placebo-controlled, parallel group trial done at 153 sites in 15 countries. Participants had an investigator-diagnosed fibrosing ILD other than IPF, with chest imaging features of fibrosis of more than 10% extent on high resolution CT (HRCT), forced vital capacity (FVC) of 45% or more predicted, and diffusing capacity of the lung for carbon monoxide (DLco) of at least 30% and less than 80% predicted. Participants fulfilled protocol-defined criteria for ILD progression in the 24 months before screening, despite management considered appropriate in clinical practice for the individual ILD. Participants were randomly assigned 1:1 by means of a pseudo-random number generator to receive nintedanib 150 mg twice daily or placebo for at least 52 weeks. Participants, investigators, and other personnel involved in the trial and analysis were masked to treatment assignment until after database lock. In this subgroup analysis, we assessed the rate of decline in FVC (mL/year) over 52 weeks in patients who received at least one dose of nintedanib or placebo in five prespecified subgroups based on the ILD diagnoses documented by the investigators: hypersensitivity pneumonitis, autoimmune ILDs, idiopathic non-specific interstitial pneumonia, unclassifiable idiopathic interstitial pneumonia, and other ILDs. The trial has been completed and is registered with ClinicalTrials.gov, number NCT02999178. FINDINGS Participants were recruited between Feb 23, 2017, and April 27, 2018. Of 663 participants who received at least one dose of nintedanib or placebo, 173 (26%) had chronic hypersensitivity pneumonitis, 170 (26%) an autoimmune ILD, 125 (19%) idiopathic non-specific interstitial pneumonia, 114 (17%) unclassifiable idiopathic interstitial pneumonia, and 81 (12%) other ILDs. The effect of nintedanib versus placebo on reducing the rate of FVC decline (mL/year) was consistent across the five subgroups by ILD diagnosis in the overall population (hypersensitivity pneumonitis 73·1 [95% CI -8·6 to 154·8]; autoimmune ILDs 104·0 [21·1 to 186·9]; idiopathic non-specific interstitial pneumonia 141·6 [46·0 to 237·2]; unclassifiable idiopathic interstitial pneumonia 68·3 [-31·4 to 168·1]; and other ILDs 197·1 [77·6 to 316·7]; p=0·41 for treatment by subgroup by time interaction). Adverse events reported in the subgroups were consistent with those reported in the overall population. INTERPRETATION The INBUILD trial was not designed or powered to provide evidence for a benefit of nintedanib in specific diagnostic subgroups. However, its results suggest that nintedanib reduces the rate of ILD progression, as measured by FVC decline, in patients who have a chronic fibrosing ILD and progressive phenotype, irrespective of the underlying ILD diagnosis. FUNDING Boehringer Ingelheim.
Collapse
Affiliation(s)
- Athol U Wells
- National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK
| | - Kevin R Flaherty
- Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA
| | - Kevin K Brown
- Department of Medicine, National Jewish Health, Denver, CO, USA
| | - Yoshikazu Inoue
- Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan
| | - Anand Devaraj
- Department of Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College, London, UK
| | - Luca Richeldi
- Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Teng Moua
- Division of Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, MN, USA
| | - Bruno Crestani
- Université de Paris, Inserm U1152, APHP, Hôpital Bichat, Centre de reference constitutif pour les maladies pulmonaires rares, Paris, France
| | - Wim A Wuyts
- Unit for Interstitial Lung Diseases, Department of Pulmonary Medicine, University Hospitals Leuven, Leuven, Belgium
| | | | - Manuel Quaresma
- Boehringer Ingelheim International, Ingelheim am Rhein, Germany
| | | | | | - Martin Kolb
- McMaster University and St Joseph's Healthcare, Hamilton, Ontario, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Takeuchi H, Ishida T, Satou Y, Gohda J, Kitamura H, Gan S, Takahashi K, Yamaoka S. Genome-wide RNAi screen identifies MAPK-RPK required for HIV-1 proviral silencing in non-T cell reservoir cell-line model. J Virus Erad 2019. [DOI: 10.1016/s2055-6640(20)30081-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
14
|
Kitamura H, Dahlan AV, Tian Y, Shimaoka T, Yamamoto T, Takahashi F. Impact of secondary generated minerals on toxic element immobilization for air pollution control fly ash of a municipal solid waste incinerator. Environ Sci Pollut Res Int 2018; 25:20700-20712. [PMID: 29754297 DOI: 10.1007/s11356-018-1959-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Accepted: 04/04/2018] [Indexed: 06/08/2023]
Abstract
Impacts of secondary generated minerals on mineralogical and physical immobilization of toxic elements were investigated for chelate-treated air pollution control (APC) fly ash of a municipal solid waste incinerator. Scanning electron microscope (SEM) observation showed that ettringite was generated after the moistening treatment with/without chelate. Although ettringite can incorporate toxic elements into its structure, elemental analysis by energy dispersive X-ray could not find concentrated points of toxic elements in ettringite structure. This implies that mineralogical immobilization of toxic element by the encapsulation to ettringite structure seems to be limited. Physical immobilization was also investigated by SEM observation of the same APC fly ash particles before and after the moistening treatment. The transfer of soluble elements was inhibited only when insoluble minerals such as gypsum were generated and covered the surface of fly ash particles. Neoformed insoluble minerals prevented soluble elements from leaching and transfer. However, such physical immobilization seems to be limited because insoluble mineral formation with surface coverage was monitored only one time of more than 20 observations. Although uncertainty owing to limited samples with limited observations should be considered, this study concludes that mineralogical and physical immobilization of toxic elements by secondary minerals is limited although secondary minerals are always generated on the surface of APC fly ash particles during chelate treatment.
Collapse
Affiliation(s)
- Hiroki Kitamura
- Global Engineering Course for Development, Environment and Society, Department of Transdisciplinary Science and Engineering, School of Environment and Society, Tokyo Institute of Technology, G5-13, 4259, Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan
- Research Fellow of Japan Society for the Promotion of Science, 5-3-1, Kojimachi, Chiyoda-ku, Tokyo, 102-0083, Japan
| | - Astryd Viandila Dahlan
- Global Engineering Course for Development, Environment and Society, Department of Transdisciplinary Science and Engineering, School of Environment and Society, Tokyo Institute of Technology, G5-13, 4259, Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan
| | - Yu Tian
- Global Engineering Course for Development, Environment and Society, Department of Transdisciplinary Science and Engineering, School of Environment and Society, Tokyo Institute of Technology, G5-13, 4259, Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan
| | - Takayuki Shimaoka
- Faculty of Urban and Environmental Engineering, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka, 819-0395, Japan
| | - Takashi Yamamoto
- Center for Material Cycles and Waste Management Research, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba, Ibaraki, 305-8506, Japan
| | - Fumitake Takahashi
- Global Engineering Course for Development, Environment and Society, Department of Transdisciplinary Science and Engineering, School of Environment and Society, Tokyo Institute of Technology, G5-13, 4259, Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan.
| |
Collapse
|
15
|
Sonpavde G, Pond GR, Di Lorenzo G, Buonerba C, Rozzi A, Lanzetta G, Necchi A, Giannatempo P, Raggi D, Matsumoto K, Choueiri TK, Mullane S, Niegisch G, Albers P, Lee JL, Kitamura H, Kume H, Bellmunt J. Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma. Clin Genitourin Cancer 2016; 14:494-498. [PMID: 27262369 DOI: 10.1016/j.clgc.2016.05.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2016] [Accepted: 05/06/2016] [Indexed: 11/24/2022]
Abstract
BACKGROUND Trials of salvage therapy for advanced urothelial carcinoma have required prior platinum-based therapy. This practice requires scrutiny because non-platinum-based first-line therapy may be offered to cisplatin-ineligible patients. PATIENTS AND METHODS Data of patients receiving salvage systemic chemotherapy were collected. Data on prior first-line platinum exposure were required in addition to treatment-free interval, hemoglobin, Eastern Cooperative Oncology Group performance status, albumin, and liver metastasis status. Cox proportional hazard regression was used to evaluate their association with overall survival (OS) after accounting for salvage single-agent or combination chemotherapy. RESULTS Data were obtained from 455 patients previously exposed to platinum-based therapy and 37 not exposed to platinum. In the group exposed to prior platinum therapy, salvage therapy consisted of a single-agent taxane (n = 184) or a taxane-containing combination chemotherapy (n = 271). In the group not exposed to prior platinum therapy, salvage therapy consisted of taxane or vinflunine (n = 20), 5-fluorouracil (n = 1), taxane-containing combination chemotherapy (n = 12), carboplatin-based combinations (n = 2), and cisplatin-based combinations (n = 2). The median OS for the prior platinum therapy group was 7.8 months (95% confidence interval, 7.0, 8.1), and for the group that had not received prior platinum therapy was 9.0 months (95% confidence interval, 6.0, 11.0; P = .50). In the multivariable analysis, prior platinum therapy versus no prior platinum exposure did not confer an independent impact on OS (hazard ratio, 1.10; 95% confidence interval, 0.75, 1.64; P = .62). CONCLUSION Prior platinum- versus non-platinum-based chemotherapy did not have a prognostic impact on OS after accounting for major prognostic factors in patients receiving salvage systemic chemotherapy for advanced urothelial carcinoma. Lack of prior platinum therapy should not disqualify patients from inclusion onto trials of salvage therapy.
Collapse
Affiliation(s)
- G Sonpavde
- UAB Comprehensive Cancer Center, Birmingham, AL.
| | - G R Pond
- McMaster University, Hamilton, Ontario, Canada
| | | | - C Buonerba
- Centro di Riferimento Oncologico della Basilicata IRCCS, Rionero in Vulture, Italy
| | - A Rozzi
- Istituto Neurotraumatologico Italiano, Grottaferrata, Italy
| | - G Lanzetta
- Istituto Neurotraumatologico Italiano, Grottaferrata, Italy
| | - A Necchi
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - P Giannatempo
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - D Raggi
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - K Matsumoto
- Kitasato University School of Medicine, Sagamihara, Japan
| | - T K Choueiri
- Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
| | - S Mullane
- Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
| | - G Niegisch
- Heinrich Heine University, Medical Faculty, Dusseldorf, Germany
| | - P Albers
- Heinrich Heine University, Medical Faculty, Dusseldorf, Germany
| | - J L Lee
- Asan Medical Center, Seoul, South Korea
| | - H Kitamura
- Sapporo Medical University School of Medicine, Sapporo, Japan
| | - H Kume
- University of Tokyo Hospital, Tokyo, Japan
| | - J Bellmunt
- Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
| |
Collapse
|
16
|
Sekizawa O, Uruga T, Takagi Y, Nitta K, Kato K, Tanida H, Uesugi K, Hoshino M, Ikenaga E, Takeshita K, Takahashi S, Sano M, Aoyagi H, Watanabe A, Nariyama N, Ohashi H, Yumoto H, Koyama T, Senba Y, Takeuchi T, Furukawa Y, Ohata T, Matsushita T, Ishizawa Y, Kudo T, Kimura H, Yamazaki H, Tanaka T, Bizen T, Seike T, Goto S, Ohno H, Takata M, Kitamura H, Ishikawa T, Tada M, Yokoyama T, Iwasawa Y. SPring-8 BL36XU: Catalytic Reaction Dynamics for Fuel Cells. ACTA ACUST UNITED AC 2016. [DOI: 10.1088/1742-6596/712/1/012142] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
17
|
Kitamura H, Sawada T, Shimaoka T, Takahashi F. Geochemically structural characteristics of municipal solid waste incineration fly ash particles and mineralogical surface conversions by chelate treatment. Environ Sci Pollut Res Int 2016; 23:734-743. [PMID: 26336844 DOI: 10.1007/s11356-015-5229-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/18/2015] [Accepted: 08/11/2015] [Indexed: 06/05/2023]
Abstract
Leaching behaviors of heavy metals contained in municipal solid waste incineration (MSWI) fly ash have been studied well. However, micro-characteristics of MSWI fly ash particles are still uncertain and might be non-negligible to describe their leaching behaviors. Therefore, this study investigated micro-characteristics of MSWI fly ash particles, especially their structural properties and impacts of chelate treatment on surface characteristics. According to SEM observations, raw fly ash particles could be categorized into four types based on their shapes. Because chelate treatment changed the surface of fly ash particles dramatically owing to secondary mineral formations like ettringite, two more types could be categorized for chelate-treated fly ash particles. Acid extraction experiments suggest that fly ash particles, tested in this study, consist of Si-base insoluble core structure, Al/Ca/Si-base semi-soluble matrices inside the body, and KCl/NaCl-base soluble aggregates on the surface. Scanning electron microscope (SEM) observations of the same fly ash particles during twice moistening treatments showed that KCl/NaCl moved under wet condition and concentrated at different places on the particle surface. However, element mobility depended on secondary mineral formations. When insoluble mineral like gypsum was generated and covered the particle surface, it inhibited element transfer under wet condition. Surface characteristics including secondary mineral formation of MSWI fly ash particles are likely non-negligible to describe trace element leaching behaviors.
Collapse
Affiliation(s)
- Hiroki Kitamura
- Department of Environmental Science and Technology, Interdisciplinary Graduate School of Science and Engineering, Tokyo Institute of Technology, 4259, Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan
| | - Takaya Sawada
- Faculty of Urban and Environmental Engineering, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka, 819-0395, Japan
| | - Takayuki Shimaoka
- Faculty of Urban and Environmental Engineering, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka, 819-0395, Japan
| | - Fumitake Takahashi
- Department of Environmental Science and Technology, Interdisciplinary Graduate School of Science and Engineering, Tokyo Institute of Technology, 4259, Nagatsuta, Midori-ku, Yokohama, 226-8503, Japan.
| |
Collapse
|
18
|
Shimizu T, Okano N, Kurata T, Naruge D, Fujisaka Y, Kitamura H, Nagashima F, Nakagawa K, Furuse J. 128O Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in Japanese patients with advanced solid tumors. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv521.04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
19
|
Nascimento L, Vanhavere F, Kodaira S, Kitamura H, Verellen D, De Deene Y. Application of Al 2 O 3 :C+fibre dosimeters for 290 MeV/n carbon therapeutic beam dosimetry. Radiat Phys Chem Oxf Engl 1993 2015. [DOI: 10.1016/j.radphyschem.2015.06.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
20
|
Kyselová D, Ambrožová I, Krist P, Kubančák J, Uchihori Y, Kitamura H, Ploc O. Calibration of modified Liulin detector for cosmic radiation measurements on-board aircraft. Radiat Prot Dosimetry 2015; 164:489-492. [PMID: 25979744 DOI: 10.1093/rpd/ncv332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The annual effective doses of aircrew members often exceed the limit of 1 mSv for the public due to the increased level of cosmic radiation at the flight altitudes, and thus, it is recommended to monitor them. Aircrew dosimetry is usually performed using special computer programs mostly based on results of Monte Carlo simulations. Contemporary, detectors are used mostly for validation of these computer codes, verification of effective dose calculations and for research purposes. One of such detectors is active silicon semiconductor deposited energy spectrometer Liulin. Output quantities of measurement with the Liulin detector are the absorbed dose in silicon D and the ambient dose equivalent H*(10); to determine it, two calibrations are necessary. The purpose of this work was to develop a calibration methodology that can be used to convert signal from the detector to D independently on calibration performed at Heavy Ion Medical Accelerator facility in Chiba, Japan.
Collapse
Affiliation(s)
- D Kyselová
- Department of Radiation Dosimetry, Nuclear Physics Institute of the ASCR, Na Truhlářce 39/64, Prague 180 00, Czech Republic Department of Dosimetry and Application of Ionizing Radiation, Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Břehová 7, Prague 115 19, Czech Republic
| | - I Ambrožová
- Department of Radiation Dosimetry, Nuclear Physics Institute of the ASCR, Na Truhlářce 39/64, Prague 180 00, Czech Republic
| | - P Krist
- Department of Accelerators, Nuclear Physics Institute ASCR, Husinec 130, Řež 250 68, Czech Republic
| | - J Kubančák
- Department of Radiation Dosimetry, Nuclear Physics Institute of the ASCR, Na Truhlářce 39/64, Prague 180 00, Czech Republic Department of Dosimetry and Application of Ionizing Radiation, Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Břehová 7, Prague 115 19, Czech Republic
| | - Y Uchihori
- National Institute of Radiological Sciences, Chiba, Japan
| | - H Kitamura
- National Institute of Radiological Sciences, Chiba, Japan
| | - O Ploc
- Department of Radiation Dosimetry, Nuclear Physics Institute of the ASCR, Na Truhlářce 39/64, Prague 180 00, Czech Republic
| |
Collapse
|
21
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Bagliesi M, Bigongiari G, Binns W, Bonechi S, Bongi M, Buckley J, Castellini G, Cherry M, Collazuol G, Ebisawa K, Di Felice V, Fuke H, Guzik T, Hams T, Hareyama M, Hasebe N, Hibino K, Ichimura M, Ioka K, Israel M, Javaid A, Kamioka E, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kawanaka N, Kitamura H, Kotani T, Krawczynski H, Krizmanic J, Kubota A, Kuramata S, Lomtadze T, Maestro P, Marcelli L, Marrocchesi P, Mitchell J, Miyake S, Mizutani K, Moiseev A, Mori K, Mori M, Mori N, Motz H, Munakata K, Murakami H, Nakagawa Y, Nakahira S, Nishimura J, Okuno S, Ormes J, Ozawa S, Palma F, Papini P, Rauch B, Ricciarini S, Sakamoto T, Sasaki M, Shibata M, Shimizu Y, Shiomi A, Sparvoli R, Spillantini P, Takahashi I, Takayanagi M, Takita M, Tamura T, Tateyama N, Terasawa T, Tomida H, Torii S, Tunesada Y, Uchihori Y, Ueno S, Vannuccini E, Wefel J, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Yuda T. The CALorimetric Electron Telescope (CALET) for high-energy astroparticle physics on the International Space Station. EPJ Web of Conferences 2015. [DOI: 10.1051/epjconf/20159504056] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
22
|
Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Glomerular capillary regeneration and endothelial cell apoptosis in both reversible and progressive models of glomerulonephritis. Contrib Nephrol 2015; 118:29-40. [PMID: 8744037 DOI: 10.1159/000425073] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
In summary, angiogenetic capillary regeneration with endothelial proliferation occurred among mesangiolytic lesions in Thy-1 GN, and the damaged glomerulus recovered its normal structure with the reconstruction of the capillary network. In anti-GBM GN on WKY rats, the damaged glomerulus showed rare capillary regeneration and progressed to global sclerosis. In Thy-1 GN, endothelial cell apoptosis was found in the regenerated capillaries with endothelial cell hypercellularity. On the other hand, in anti-GBM GN on WKY rats, the number of endothelial cell apoptosis increased during the evolution of glomerular sclerosis. We have concluded that glomerular capillary regeneration plays an essential role in the recovery of damaged glomeruli. Moreover, apoptosis is indispensable in regulating the number of intrinsic endothelial cells. We also found that endothelial apoptosis is important in progression of glomerular sclerosis.
Collapse
Affiliation(s)
- A Shimizu
- Department of Pathology, Nippon Medical School, Tokyo, Japan
| | | | | | | | | | | |
Collapse
|
23
|
Korekawa A, Nakano H, Aizu T, Kitamura H, Harada K, Sawamura D. A reddish, pedunculated, granulomatous nodule on the nasal dorsum. Clin Exp Dermatol 2015; 40:703-5. [PMID: 25703862 DOI: 10.1111/ced.12613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/19/2014] [Indexed: 11/30/2022]
Affiliation(s)
- A Korekawa
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - H Nakano
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - T Aizu
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - H Kitamura
- Department of Dermatology, Aomori Prefectural Central Hospital, Aomori, Japan
| | - K Harada
- Department of Dermatology, Aomori Prefectural Central Hospital, Aomori, Japan
| | - D Sawamura
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| |
Collapse
|
24
|
Dachev TP, Semkova JV, Tomov BT, Matviichuk YN, Dimitrov PG, Koleva RT, Malchev S, Bankov NG, Shurshakov VA, Benghin VV, Yarmanova EN, Ivanova OA, Häder DP, Lebert M, Schuster MT, Reitz G, Horneck G, Uchihori Y, Kitamura H, Ploc O, Cubancak J, Nikolaev I. Overview of the Liulin type instruments for space radiation measurement and their scientific results. Life Sci Space Res (Amst) 2015; 4:92-114. [PMID: 26177624 DOI: 10.1016/j.lssr.2015.01.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2014] [Revised: 01/15/2015] [Accepted: 01/26/2015] [Indexed: 05/24/2023]
Abstract
Ionizing radiation is recognized to be one of the main health concerns for humans in the space radiation environment. Estimation of space radiation effects on health requires the accurate knowledge of the accumulated absorbed dose, which depends on the global space radiation distribution, solar cycle and local shielding generated by the 3D mass distribution of the space vehicle. This paper presents an overview of the spectrometer-dosimeters of the Liulin type, which were developed in the late 1980s and have been in use since then. Two major measurement systems have been developed by our team. The first one is based on one silicon detector and is known as a Liulin-type deposited energy spectrometer (DES) (Dachev et al., 2002, 2003), while the second one is a dosimetric telescope (DT) with two or three silicon detectors. The Liulin-type instruments were calibrated using a number of radioactive sources and particle accelerators. The main results of the calibrations are presented in the paper. In the last section of the paper some of the most significant scientific results obtained in space and on aircraft, balloon and rocket flights since 1989 are presented.
Collapse
Affiliation(s)
- T P Dachev
- Space Research and Technology Institute, Bulgarian Academy of Sciences, Sofia, Bulgaria.
| | - J V Semkova
- Space Research and Technology Institute, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - B T Tomov
- Space Research and Technology Institute, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Yu N Matviichuk
- Space Research and Technology Institute, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - P G Dimitrov
- Space Research and Technology Institute, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - R T Koleva
- Space Research and Technology Institute, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - St Malchev
- Space Research and Technology Institute, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - N G Bankov
- Space Research and Technology Institute, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - V A Shurshakov
- State Research Center Institute of Biomedical Problems, Russian Academy of Science, Moscow, Russia
| | - V V Benghin
- State Research Center Institute of Biomedical Problems, Russian Academy of Science, Moscow, Russia
| | - E N Yarmanova
- State Research Center Institute of Biomedical Problems, Russian Academy of Science, Moscow, Russia
| | - O A Ivanova
- State Research Center Institute of Biomedical Problems, Russian Academy of Science, Moscow, Russia
| | - D-P Häder
- Neue Str. 9, 91096 Möhrendorf, Germany
| | - M Lebert
- Friedrich-Alexander-Universität, Department for Biology, Erlangen, Germany
| | - M T Schuster
- Friedrich-Alexander-Universität, Department for Biology, Erlangen, Germany
| | - G Reitz
- DLR, Institute of Aerospace Medicine, Köln, Germany
| | - G Horneck
- DLR, Institute of Aerospace Medicine, Köln, Germany
| | - Y Uchihori
- National Institute of Radiological Sciences-STA, Chiba, Japan
| | - H Kitamura
- National Institute of Radiological Sciences-STA, Chiba, Japan
| | - O Ploc
- Nuclear Physics Institute, Czech AS, Prague, Czech Republic
| | - J Cubancak
- Nuclear Physics Institute, Czech AS, Prague, Czech Republic
| | - I Nikolaev
- S.P. Korolev Rocket and Space Corporation Energia, Moscow, Russia
| |
Collapse
|
25
|
Takamura H, Nakanuma S, Hayashi H, Tajima H, Kakinoki K, Kitahara M, Sakai S, Makino I, Nakagawara H, Miyashita T, Okamoto K, Nakamura K, Oyama K, Inokuchi M, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Onishi I, Kayahara M, Tani T, Arai K, Yamashita T, Yamashita T, Kitamura H, Ikeda H, Kaneko S, Nakanuma Y, Matsui O, Ohta T. Severe Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Deceased-donor and Living-donor Liver Transplantation. Transplant Proc 2014; 46:3523-35. [DOI: 10.1016/j.transproceed.2014.09.110] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2014] [Accepted: 09/17/2014] [Indexed: 12/13/2022]
|
26
|
Saigo K, Otsuki K, Hasegawa M, Maruyama M, Akutsu N, Aoyama H, Matsumoto I, Noguchi H, Asano T, Kitamura H. 329. The impact of gemcitabine plus S-1 combination therapy in patients with highly advanced or recurrent pancreatic and biliary tract cancers. Eur J Surg Oncol 2014. [DOI: 10.1016/j.ejso.2014.08.319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
27
|
Kasutani K, Fujii E, Ohyama S, Adachi H, Hasegawa M, Kitamura H, Yamashita N. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol 2014; 171:5049-58. [PMID: 24946165 DOI: 10.1111/bph.12823] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2013] [Revised: 05/27/2014] [Accepted: 06/11/2014] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND AND PURPOSE IL-31, which is described as a pruritogenic cytokine, is linked to the itching that is associated with allergic and non-allergic eczema, but the precise pruritogenic mechanism of IL-31 and its potential as a therapeutic target for atopic dermatitis (AD) have not been determined. EXPERIMENTAL APPROACH We investigated the effects of existing drugs on the scratching behaviour induced by an i.v. injection of IL-31 to clarify whether IL-31 induced pruritus indirectly. In addition, we studied the effects of an anti-IL-31 receptor α subunit (anti-IL-31 receptor α) neutralizing antibody on chronic pruritus-inducing dermatitis in an AD-like model to determine whether IL-31 not only induces scratching behaviour, but is also the causative factor in an AD phenotype. KEY RESULTS The scratching behaviour induced by an i.v. injection of IL-31 was inhibited by pretreatment with an anti-IL-31 receptor α-neutralizing antibody. In contrast, it was not inhibited significantly by a non-sedative antihistamine (terfenadine), immunosuppressants (dexamethasone and tacrolimus), or a μ-opioid receptor antagonist (naloxone). The anti-IL-31 receptor α-neutralizing antibody reduced the ear swelling and dermatitis score in a chronic pruritus-inducing AD-like model. Moreover, treatment with the anti-IL-31 receptor α-neutralizing antibody showed therapeutic effects on the dermatitis even if it was injected after the disease had developed. CONCLUSIONS AND IMPLICATIONS Anti-IL-31 receptor α is a potential novel therapeutic approach for escaping from the itch-scratch cycle and also a treatment for dermatitis in AD.
Collapse
Affiliation(s)
- K Kasutani
- Department of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan; Research Division, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
| | | | | | | | | | | | | |
Collapse
|
28
|
Kitamura H, Terunuma N, Kurosaki S, Hata K, Masuda M, Kochi T, Yanagi N, Murase T, Ogami A, Higashi T. A cohort study of toner-handling workers on inflammatory, allergic, and oxidative stress markers. Hum Exp Toxicol 2014; 34:337-44. [DOI: 10.1177/0960327113512339] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Objectives: This study examines the relationship between toner exposure and its health effects in terms of biomarkers which are known to assess the damages to humans caused by toxic material exposure. Methods: The subjects were 1504 male workers aged below 50 in 2003 in a Japanese toner and photocopier manufacturing company. Personal exposure measurements, pulmonary function tests, chest X-ray examinations, biomarker measurement, and a questionnaire about respiratory symptoms were conducted. We will report about biomarker measurement in this study. Cross-sectional survey studies and a longitudinal study from 2003 to 2008 were conducted. Results: Few significant findings were associated with the toner exposure in both the cross-sectional and the longitudinal studies. The higher toner exposure concentrations did not induce effects on increasing biomarkers. Conclusion: There was no evidence of excessive inflammatory, allergic, or oxidative stress reaction in toner-handling workers as compared to non-handling workers, despite some sporadically significant findings. There are no other reports of a longitudinal epidemiological study with regard to toner exposure; this report significantly contributes to toner exposure literature. Although in the current well-controlled working environment, the toner exposure concentrations are quite low; further studies are needed to completely understand the health effects toner may have, however small they may be.
Collapse
Affiliation(s)
- H Kitamura
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - N Terunuma
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - S Kurosaki
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - K Hata
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - M Masuda
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Kochi
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - N Yanagi
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Murase
- Department of Haematology, Tokai University School of Medicine, Hachioji, Japan
| | - A Ogami
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Higashi
- Department of Work Systems and Health, Institute of Industrial Ecological Science, University of Occupational and Environmental Health, Kitakyushu, Japan
| |
Collapse
|
29
|
Kitamura H, Terunuma N, Kurosaki S, Hata K, Masuda M, Kochi T, Yanagi N, Murase T, Ogami A, Higashi T. A cohort study using pulmonary function tests and x-ray examination in toner-handling workers: cross-sectional and longitudinal analyses from 2003 to 2008. Hum Exp Toxicol 2014; 34:345-56. [PMID: 25034943 DOI: 10.1177/0960327113520018] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVES This study uses pulmonary function tests and chest x-ray examinations to examine the relationship between toner-handling work and its health effects. METHODS The subjects were 1504 male workers in a Japanese toner and photocopier manufacturing company, in the age range from 19 to 50 years in 2003. Personal exposure measurements, pulmonary function tests, chest x-ray examinations, biomarker measurements, and a questionnaire about respiratory symptoms were conducted. The present study reports the results of pulmonary function tests and chest x-ray examinations conducted in the subjects, which includes a cross-sectional study on the toner handling and non-handling workers and a longitudinal study from 2003 to 2008. RESULTS Few significant findings were suspected to be caused by toner exposure found in pulmonary function indices in both the cross-sectional and longitudinal studies. Any obvious fibrotic findings in chest x-ray findings related to the toner exposure could not be found out. CONCLUSION No evidence of adverse effects on pulmonary function indices and chest x-rays was present in the toner-handling workers as compared to the nonspecifically exposed workers. Although the toner exposure concentration is quite low in the current well-controlled working environment, even among the toner-handling workers, we would like to continue this study in the future to verify the toner exposure health effects.
Collapse
Affiliation(s)
- H Kitamura
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - N Terunuma
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - S Kurosaki
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - K Hata
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - M Masuda
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Kochi
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - N Yanagi
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Murase
- Department of Haematology, Tokai University School of Medicine, Hachioji, Japan
| | - A Ogami
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Higashi
- Department of Work Systems and Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan
| |
Collapse
|
30
|
Kitamura H, Tsukamoto T, Shibata T, Masumori N, Fujimoto H, Hirao Y, Fujimoto K, Kitamura Y, Tomita Y, Tobisu K, Niwakawa M, Naito S, Eto M, Kakehi Y. Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209. Ann Oncol 2014; 25:1192-8. [PMID: 24669010 DOI: 10.1093/annonc/mdu126] [Citation(s) in RCA: 80] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND This study aimed to determine the clinical benefit of neoadjuvant methotrexate, doxorubicin, vinblastine, and cisplatin (MVAC) in patients with muscle-invasive bladder cancer (MIBC) treated with radical cystectomy. PATIENTS AND METHODS Patients with MIBC (T2-4aN0M0) were randomised to receive two cycles of neoadjuvant MVAC followed by radical cystectomy (NAC arm) or radical cystectomy alone (RC arm). The primary end point was overall survival (OS). Secondary end points were progression-free survival, surgery-related complications, adverse events during chemotherapy, proportion with no residual tumour in the cystectomy specimens, and quality of life. To detect an improvement in 5-year OS from 45% in the RC arm to 57% in the NAC arm with 80% power, 176 events were required per arm. RESULTS Patients (N = 130) were randomly assigned to the RC arm (N = 66) and the NAC arm (N = 64). The patient registration was terminated before reaching the initially planned number of patients because of slow accrual. At the second interim analysis just after the early stoppage of patient accrual, the Data and Safety Monitoring Committee recommended early publication of the results because the trial did not have enough power to draw a confirmatory conclusion. OS of the NAC arm was better than that of the RC arm, although the difference was not statistically significant [hazard ratio 0.65, multiplicity adjusted 99.99% confidence interval 0.19-2.18, one-sided P = 0.07]. In the NAC arm and the RC arm, 34% and 9% of the patients had pT0, respectively (P < 0.01). In subgroup analyses, OS in almost all subgroups was in favour of NAC. CONCLUSIONS This trial showed a significantly increased pT0 proportion and favourable OS of patients who received neoadjuvant MVAC. NAC with MVAC can still be considered promising as a standard treatment. UMIN CLINICAL TRIALS REGISTRY IDENTIFIER C000000093.
Collapse
Affiliation(s)
- H Kitamura
- Department of Urology, Sapporo Medical University School of Medicine, Sapporo
| | - T Tsukamoto
- Department of Urology, Sapporo Medical University School of Medicine, Sapporo
| | - T Shibata
- Japan Clinical Oncology Group Data Centre, Multi-institutional Clinical Trial Support Centre, National Cancer Centre, Tokyo
| | - N Masumori
- Department of Urology, Sapporo Medical University School of Medicine, Sapporo
| | - H Fujimoto
- Department of Urology, National Cancer Centre Hospital, Tokyo
| | - Y Hirao
- Department of Urology, Nara Medical University, Kashihara
| | - K Fujimoto
- Department of Urology, Nara Medical University, Kashihara
| | - Y Kitamura
- Department of Urology, Niigata Cancer Centre Hospital, Niigata
| | - Y Tomita
- Department of Urology, Yamagata University Faculty of Medicine, Yamagata
| | - K Tobisu
- Department of Urology, Shizuoka Cancer Centre Hospital, Shizuoka
| | - M Niwakawa
- Department of Urology, Shizuoka Cancer Centre Hospital, Shizuoka
| | - S Naito
- Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka
| | - M Eto
- Department of Urology, Faculty of Life Sciences, Kumamoto University, Kumamoto
| | - Y Kakehi
- Department of Urology, Kagawa University Faculty of Medicine, Kagawa, Japan
| | | |
Collapse
|
31
|
Aoyama H, Saigo K, Hasegawa M, Akutsu N, Maruyama M, Otsuki K, Matsumoto I, Kawaguchi T, Kitamura H, Asano T, Kenmochi T, Itou T, Matsubara H. Pathologic Findings of Renal Biopsy Were a Helpful Diagnostic Clue of Stenosis of the Iliac Segment Proximal to the Transplant Renal Artery: A Case Report. Transplant Proc 2014; 46:651-3. [DOI: 10.1016/j.transproceed.2013.11.140] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2013] [Revised: 11/18/2013] [Accepted: 11/27/2013] [Indexed: 11/25/2022]
|
32
|
Pinsky LS, Idarraga-Munoz J, Kroupa M, Son H, Stoffle N, Semones E, Bahadori A, Turecek D, Pospíšil S, Jakubek J, Vykydal Z, Kitamura H, Uchihori Y. Medipix in space on-board the ISS. J Radiat Res 2014; 55:i62-i63. [PMCID: PMC3941488 DOI: 10.1093/jrr/rrt197] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
On 16 October 2012, five active radiation detectors (referred to by NASA as Radiation Environment Monitors, or REMs) employing the Timepix version of the technology developed by the CERN-based Medipix2 Collaboration were deployed on-board the International Space Station (ISS) using simple USB interfaces to the existing ISS laptops for power, control and readout [
1–
3]. These devices successfully demonstrated the capabilities of this technology by providing reliable dose and dose-equivalent information based on a track-by-track analysis. Figure 1 shows a sample comparison of the output from all five devices with respect to the on-board tissue equivalent proportional counter (TEPC) for both absorbed dose (top) and dose-equivalent (bottom) as defined in NCRP 142. The lower graph in each set is the TEPC. Several issues were identified and solutions to adjust for them have been included in the analysis. These include items such as the need to identify nuclear interactions in the silicon sensor layer, and to separate penetrating from stopping tracks. The wide effective range in fluence and particle type of this technology was also verified through the highest rates seen during the South Atlantic Anomaly passes and the heavy ions nominally seen in the Galactic Cosmic Rays. Corrections for detector response saturation effects were also successfully implemented as verified by reference to ground-based accelerator data taken at the Heavy-Ion Medical Accelerator Center (HIMAC) facility at the National Institute for Radiological Sciences in Japan, and at the NASA Space Radiation Laboratory (NSRL) at the Brookhaven National Laboratory in New York. Flight hardware has been produced that will be flown on the first launch of the new Orion spacecraft, and flight hardware development is ongoing to accommodate the next generation of this technology as a baseline for radiation monitoring and dosimetry on future operational manned missions.
Five ISS REM units compared with ISS IVTEPC in absorbed dose (a) and dose-equivalent (b). ![]()
Collapse
Affiliation(s)
- Lawrence S. Pinsky
- Physics Department, University of Houston, 4800 Calhoun Rd, Houston, TX 77201-5005, USA
| | - J. Idarraga-Munoz
- Physics Department, University of Houston, 4800 Calhoun Rd, Houston, TX 77201-5005, USA
| | - M. Kroupa
- Physics Department, University of Houston, 4800 Calhoun Rd, Houston, TX 77201-5005, USA
| | - H.M. Son
- Physics Department, University of Houston, 4800 Calhoun Rd, Houston, TX 77201-5005, USA
| | - N.N. Stoffle
- Physics Department, University of Houston, 4800 Calhoun Rd, Houston, TX 77201-5005, USA
| | | | | | - D. Turecek
- Institute for Experimental and Applied Physics, Czech Technical University in Prague, Czech Republic
| | - S. Pospíšil
- Institute for Experimental and Applied Physics, Czech Technical University in Prague, Czech Republic
| | - J. Jakubek
- Institute for Experimental and Applied Physics, Czech Technical University in Prague, Czech Republic
| | - Z. Vykydal
- Institute for Experimental and Applied Physics, Czech Technical University in Prague, Czech Republic
| | - H. Kitamura
- National Institute for Radiological Sciences, Inage, Japan
| | - Y. Uchihori
- National Institute for Radiological Sciences, Inage, Japan
| |
Collapse
|
33
|
Hasegawa M, Ito T, Saigo K, Akutsu N, Maruyama M, Otsuki K, Aoyama H, Matsumoto I, Asano T, Kitamura H, Kenmochi T. Association of DNA Amplification With Progress of BK Polyomavirus Infection and Nephropathy in Renal Transplant Recipients. Transplant Proc 2014; 46:556-9. [DOI: 10.1016/j.transproceed.2013.11.114] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2013] [Accepted: 11/15/2013] [Indexed: 01/10/2023]
|
34
|
Tanida H, Fukuda K, Murayama H, Orikasa Y, Arai H, Uchimoto Y, Matsubara E, Uruga T, Takeshita K, Takahashi S, Sano M, Aoyagi H, Watanabe A, Nariyama N, Ohashi H, Yumoto H, Koyama T, Senba Y, Takeuchi T, Furukawa Y, Ohata T, Matsushita T, Ishizawa Y, Kudo T, Kimura H, Yamazaki H, Tanaka T, Bizen T, Seike T, Goto S, Ohno H, Takata M, Kitamura H, Ishikawa T, Ohta T, Ogumi Z. RISING beamline (BL28XU) for rechargeable battery analysis. J Synchrotron Radiat 2014; 21:268-72. [PMID: 24365948 PMCID: PMC3874024 DOI: 10.1107/s1600577513025733] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/13/2013] [Accepted: 09/17/2013] [Indexed: 06/03/2023]
Abstract
The newly installed BL28XU beamline at SPring-8 is dedicated to in situ structural and electronic analysis of rechargeable batteries. It supports the time range (1 ms to 100 s) and spatial range (1 µm to 1 mm) needed for battery analysis. Electrochemical apparatus for battery charging and discharging are available in experimental hutches and in a preparation room. Battery analysis can be carried out efficiently and effectively using X-ray diffraction, X-ray absorption fine-structure analysis and hard X-ray photoelectron spectroscopy. Here, the design and performance of the beamline are described, and preliminary results are presented.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - K. Takeshita
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - S. Takahashi
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | | | | | | | - N. Nariyama
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - H. Ohashi
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | | | | | | | | | - Y. Furukawa
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - T. Ohata
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | | | | | - T. Kudo
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - H. Kimura
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | | | - T. Tanaka
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - T. Bizen
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - T. Seike
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - S. Goto
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | | | - M. Takata
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - H. Kitamura
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - T. Ishikawa
- JASRI/SPring-8, Japan
- Riken Harima Institute, Japan
| | - T. Ohta
- Ritsumeikan University, Japan
| | | |
Collapse
|
35
|
Kitamura H, Yakabe T, Suzuki K, Tokumaru S, Yamamoto M, Aragane N, Kimura S. An Autopsy Case Report of Double Cancer of Esophageal Cancer and Gastric Cancer Developed Various Metastases. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt460.60] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Nishiyama N, Kitamura H, Maeda T, Takahashi S, Masumori N, Hasegawa T, Tsukamoto T. Clinicopathological Analysis of Patients with Non-muscle-invasive Bladder Cancer: Prognostic Value and Clinical Reliability of the 2004 WHO Classification System. Jpn J Clin Oncol 2013; 43:1124-31. [DOI: 10.1093/jjco/hyt120] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
|
37
|
Sekizawa O, Uruga T, Tada M, Nitta K, Kato K, Tanida H, Takeshita K, Takahashi S, Sano M, Aoyagi H, Watanabe A, Nariyama N, Ohashi H, Yumoto H, Koyama T, Senba Y, Takeuchi T, Furukawa Y, Ohata T, Matsushita T, Ishizawa Y, Kudo T, Kimura H, Yamazaki H, Tanaka T, Bizen T, Seike T, Goto S, Ohno H, Takata M, Kitamura H, Ishikawa T, Yokoyama T, Iwasawa Y. New XAFS beamline for structural and electronic dynamics of nanoparticle catalysts in fuel cells under operating conditions. ACTA ACUST UNITED AC 2013. [DOI: 10.1088/1742-6596/430/1/012020] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
38
|
Kodaira S, Yasuda N, Konishi T, Kitamura H, Kurano M, Kawashima H, Uchihori Y, Ogura K, Benton E. Calibration of CR-39 with atomic force microscope for the measurement of short range tracks from proton-induced target fragmentation reactions. RADIAT MEAS 2013. [DOI: 10.1016/j.radmeas.2012.10.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
39
|
Abstract
OBJECTIVES Exercise of the leg with external limb compression has been reported to be useful for preventing and reducing leg oedema. The aim of this study was to investigate the effects of leg gaiters on calf muscle pump activity. METHODS Continuous measurements of the interface pressure at the leg during exercise and determination of the femoral venous velocity at the groin during exercise were carried out in healthy volunteers with elastic stockings alone, leg gaiters alone and gaiters over the elastic stockings. RESULTS The greatest pressure difference between muscle contraction and relaxation during exercise was observed when gaiters were applied over the elastic stockings at the calf. Gaiters alone without elastic stockings led to a significantly greater pressure difference between muscle contraction and relaxation during exercise than elastic stockings alone (P < 0.01). A significantly higher value of the peak flow velocity of the femoral vein was observed with the combined use of gaiters and elastic stockings than the single use of elastic stockings. CONCLUSIONS Leg gaiters have a beneficial effect of augmenting venous femoral blood flow during calf muscle pump activity in volunteers with a normal valve function of leg veins.
Collapse
Affiliation(s)
- M Hirai
- Department of Vascular Surgery, Tohkai Hospital, Chikusaku, Nagoya, Japan.
| | | | | | | | | | | | | |
Collapse
|
40
|
Kitamura H, Igarashi M, Tanaka T, Shindo T, Masumori N, Tamakawa M, Kawaai Y, Tsukamoto T. A Role for Preoperative Systemic Chemotherapy in Node-positive Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy. Jpn J Clin Oncol 2012; 42:1192-6. [DOI: 10.1093/jjco/hys166] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
41
|
Nagashima F, Kitamura H, Miyajima K, Takasu A, Kasuga A, Furuse J, Onaya H, Ogawa A. Planning for Community-Based Coorperation at Kyorin University Hospital by Diagnostic Imaging and Comprehensive Assessment. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32335-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
42
|
Kitamura H, Fukuta F, Nishiyama N, Tanaka T, Masumori N, Tsukamoto T. Palonostron with Aprepitant–Dexamethasone to Prevent Chemotherapy-Induced Nausea and Vomiting During Gemcitabine/Cisplatin in Urothelial Cancer Patients. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32423-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
43
|
Kawakami K, Matsunoki A, Kotake M, Kaneko M, Kitamura H, Watanabe G, Minamoto T. 1051 Knockdown of LINE-1 Enhances Sensitivity to 5-FU in LINE-1-hypomethylated Colorectal Cancer Cell. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)71662-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
44
|
Turgutalp K, Ozhan O, Akbay E, Tiftik N, Ozcan T, Yilmaz S, Kiykim A, Wu HY, Peng YS, Huang JW, Wu KD, Tu YK, Chien KL, Kacso IM, Moldovan D, Lenghel A, Rusu CC, Gherman Caprioara M, Silva AP, Fragoso A, Pinho A, Silva C, Santos N, Tavares N, Faisca M, Camacho A, Mesquita F, Leao P, Silva AP, Silva C, Santos N, Rato F, Fragoso A, Pinho A, Faisca M, Mesquita F, Leao P, Silva AP, Silva C, Santos N, Rato F, Fragoso A, Pinho A, Faisca M, Mesquita F, Leao P, Oh DJ, Kim HR, Kim SH, Okasha K, Sweilam M, Nagy H, Hassan Rizk M, Kirkpantur A, Afsar B, Chae DW, Chin HJ, Kim S, Fallahzadeh Abarghouei MK, Dormanesh B, Roozbeh J, Kamali-Sarvestani E, Vessal G, Pakfetrat M, Sagheb MM, Imasawa T, Nishimura M, Kawaguchi T, Ishibashi R, Kitamura H, Vlad A, Petrica L, Petrica M, Jianu DC, Gluhovschi G, Ianculescu C, Negru M, Dumitrascu V, Gadalean F, Zamfir A, Popescu C, Giju S, Gluhovschi C, Velciov S, Milas O, Balgradean C, Ursoniu S, Afsar B, Silva AP, Pinho A, Fragoso A, Silva C, Santos N, Faisca M, Mesquita F, Leao P, Soltysiak J, Zachwieja J, Fichna P, Lipkowska K, Skowronska B, Stankiewicz W, Stachowiak-Lewandowska M, Kluska-Jozwiak A, Afghahi H, Prasad N, Bhadauria D, Gupta A, Sharma RK, Gupta A, Kaul A, Jain M, Loboda O, Dudar I, Korol L, Shifris I, Ito K, Ito K, Abe Y, Ogahara S, Yasuno T, Watanabe M, Sasatomi Y, Hisano S, Nakashima H, Saito T, Nogaibayeva A, Tuganbekova S, Taubaldiyeva Z, Bekishev B, Trimova R, Topchii I, Topchii I, Semenovykh P, Galchiskaya V, Efimova N, Scherban T, Yasuda F, Shimizu A, MII A, Fukui M, Postorino M, Alessi E, Dal Moro E, Postorino S, Mannino G, Giandalia A, Mannino D, Pontrelli P, Conserva F, Accetturo M, Papale M, DI Palma AM, Cordisco G, Grandaliano G, Gesualdo L, Kimoto E, Shoji T, Sonoda M, Shima H, Tsuchikura S, Mori K, Emoto M, Ishimura E, Nishizawa Y, Inaba M, Vogel C, Scholbach T, Bergner N, Lioudaki E, Lioudaki E, Stylianou K, Maragkaki E, Stratakis S, Panteri M, Choulaki C, Vardaki E, Ganotakis E, Daphnis E, Iqbal M, Ahmed Z, Mansur M, Iqbal S, Choudhury S, Nahar N, Ali S, Ahmed T, Alam A, Rahman Z, Islam M, Azad Khan A, Ogawa A, Sugiyama H, Kitagawa M, Morinaga H, Inoue T, Takiue K, Kikumoto Y, Uchida HA, Kitamura S, Maeshima Y, Tsuchiyama Y, Makino H, Nazemian F, Jafari M, Zahed NOS, Javidi Dasht Bayaz R, Papale M, DI Paolo S, Vocino G, DI Palma A, Federica C, Rocchetti MT, Grandaliano G, Gesualdo L, Prajitno CW, Ismail G, Ditoiu A, Stanciu S, Herlea V, Motoi O, Striker G, Uribarri J, Vlassara H, Gul B, Oz Gul O, Yildiz A, Eroglu A, Keni N, Ersoy C, Ersoy A, Imamoglu S, Yurtkuran M. Diabetes - Clinical. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
45
|
Tajima M, Wakita D, Satoh T, Kitamura H, Nishimura T. IL-17/IFN- double producing CD8+ T (Tc17/IFN- ) cells: A novel cytotoxic T-cell subset converted from Tc17 cells by IL-12. Int Immunol 2011; 23:751-9. [DOI: 10.1093/intimm/dxr086] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
|
46
|
Tanaka T, Kato S, Kitamura H, Masumori N, Kawaai Y, Tamakawa M, Tsukamoto T. UP-01.178 Does Multidetector Row Computed Tomography Improve Accuracy in T Staging of Upper Urinary Tract Urothelial Carcinoma? Urology 2011. [DOI: 10.1016/j.urology.2011.07.729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
47
|
Inoue K, Kitamura H, Nagasawa Y, Kawada N, Isaka Y, Rakugi H. Campylobacter fetus peritonitis in a patient with an unused embedded subcutaneous peritoneal catheter. Perit Dial Int 2011; 30:253-4. [PMID: 20200376 DOI: 10.3747/pdi.2009.00078] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
48
|
Nagasaki Y, Yoshitomi T, Hirayama A, Schock-Kusch D, Xie Q, Shulhevich Y, Hesser J, Stsepankou S, Koenig S, Heinrich R, Pill J, Gretz N, Efrati S, Berman S, Abu-Hamad R, Siman-Tov Y, Weissgarten J, Kimura T, Takabatake Y, Takahashi A, Kaimori JY, Matsui I, Namba T, Kitamura H, Niimura F, Matsusaka T, Rakugi H, Isaka Y, Ito K, Watanabe M, Nakashima H, Abe Y, Ifuku M, Nishimura S, Saito T, Mulay SR, Thomasova D, Ryu M, Anders HJ, Nakayama Y, Ueda S, Yamagishi SI, Ando R, Kaida Y, Iwatani R, Fujimi A, Fukami K, Okuda S, Shin YT, Jeong JY, Jang WI, Chung S, Choi DE, Na KR, Lee KW, Mugitani N, Shimizu Y, Satake K, Suzuki Y, Horikoshi S, Tomino Y, Schneider R, Meusel M, Betz B, Wanner C, Koepsell H, Sauvant C, Dursun B, Abban G, Kucukatay V, Tufan L, Dodurga Y, Guclu A, Gok D, Vicente-Vicente L, Sanchez-Gonzalez PD, Prieto M, Lopez-Novoa JM, Lopez-Hernandez FJ, Morales AI, Torres A, Dnyanmote A, Wu W, Nigam S, Wystrychowski A, Wystrychowski W, Kolodziejczyk A, Obuchowicz E, Wiecek A, Sanchez-Gonzalez PD, Vicente-Vicente L, Prieto M, Lopez-Hernandez FJ, Lopez-Novoa JM, Morales AI, Reis LA, Borges FT, Simoes MDJ, Schor N, Mesnard L, Rafat C, Vandermeersch S, Nochy D, Garcon L, Callard P, Jouanneau C, Verpont MC, Hertig A, Rondeau E, Grosjean F, Torreggiani M, Esposito V, Mangione F, Serpieri N, Villa L, Sileno G, Marchi G, Fasoli G, Esposito C, Dal Canton A, Sancho-Martinez S, Lopez-Novoa JM, Lopez-Hernandez FJ, Esposito V, Grosjean F, Striker G, Vlassara H, Zheng F, Park DJ, Kim JH, Jung MH, Seo JW, Kim HJ, Chang SH, Han BG, Yang JW, Yu JM, Choi SO, Efrati S, Berman S, Abu-Hamad R, Siman-Tov Y, Weissgarten J, Reis LA, Christo JS, Simoes MDJ, Schor N, Rusai K, Prokai A, Szebeni B, Meszaros K, Fekete A, Treszl A, Vannay A, Muller V, Reusz G, Heemann U, Tulassay T, Lutz J, Szabo AJ, Ranghino A, Bruno S, Grange C, Dolla C, Cantaluppi V, Biancone L, Tetta C, Segoloni GP, Camussi G, Pinto V, Teixeira V, Almeida W, Schor N, Reis LA, Borges FT, Simoes MDJ, Schor N, Fujikura T, Sun Y, Iwakura T, Yasuda H, Fujigaki Y, Simone S, Rascio F, Loverre A, Cosola C, Cariello M, Castellano G, Ditonno P, Schena FP, Gesualdo L, Grandaliano G, Pertosa G, Choi JY, Kim J, Jin DC, Cha JH, Vicente-Vicente L, Prieto M, Sanchez-Gonzalez PD, Lopez-Novoa JM, Lopez-Hernandez FJ, Morales AI, Kaynar K, Aliyazicioglu R, Ersoz S, Ulusoy S, Al S, Ozkan G, Cansiz M, Fuchs TC, Emde B, Czasch S, von Landenberg F, Hewitt P, Abu-Salah N, Bishara B, Awad H, Ghrayeb N, Assady S, Armaly Z, Better O, Abassi Z. Acute kidney injury - Experimental models. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
McCabe K, Shobeiri N, Beseau D, Adams M, Holden R, Shobeiri N, Adams M, Holden R, Maio T, McCabe K, Laverty K, Beseau D, Pang J, Jozefacki A, Shobeiri N, Holden R, Adams M, Salem S, Jankowski V, Passlick-Deetjen J, Peter M, Zidek W, Jankowski J, Riser B, Barreto F, Valaitis P, Cook C, White J, Drueke T, Holmes C, Massy Z, Mizobuchi M, Ogata H, Kumata C, Nakazawa A, Koiwa F, Kinugasa E, Akizawa T, Lopez I, Aguilera-Tejero E, Guerrero F, Pineda C, Raya AI, Peralta A, Rodriguez M, Ciceri P, Volpi E, Brenna I, Brancaccio D, Cozzolino M, Bozic M, deRoij J, Parisi E, Ruiz-Ortega M, Fernandez E, Valdivielso JM, Lee CT, Ng HY, Tsai YC, Yang YK, Niwa T, Adijiang A, Shimizu H, Nishijima F, Okamoto T, Kamata K, Naito S, Aoyama T, Tazaki H, Yamanaka N, Koenigshausen E, Ohlsson S, Woznowski M, Quack I, Potthoff SA, Rump LC, Sellin L, Maquigussa E, Pereira L, Arnoni C, Boim M, Lee KW, Jeong JY, Jang WI, Chung S, Choi DE, Na KR, Shin YT, Slabiak-Blaz N, Adamczak M, Ritz E, Wiecek A, Uz E, Uz B, Sahin Balcik O, Kaya A, Akdeniz D, Bavbek Ruzgaresen N, Uz E, Turgut FH, Bayrak R, Carlioglu A, Akcay A, Galichon P, Vittoz N, Cornaire E, Baugey E, Vandermeersch S, Verpont MC, Mesnard L, Xu-Dubois YC, Hertig A, Rondeau E, Kokeny G, Fekeshazy O, Fang L, Rosivall L, Mozes MM, Duggan K, Hodge G, Ha H, Chen J, Lee L, Tay C, Macdonald G, Wang PHM, Tamouza H, Chemouny J, Monsinjon E, Tiwari M, Vende F, Vrtovsnik F, Camara NO, Benhamou M, Monteiro RC, Moura IC, Rigothier C, Saleem M, Ripoche J, Mathieson P, Combe C, Welsh G, Duwel A, Munoz-Felix JM, Lopez-Novoa JM, Martinez-Salgado C, Koutroutsos K, Kassimatis T, Nomikos A, Giannopoulou I, Papadakis J, Nakopoulou L, Nakamichi T, Mori T, Sato T, Sato H, Ito S, Neudecker S, Heilmann M, Kramer P, Wolf I, Sticht C, Schock-Kusch D, Gubhaju L, Kriz W, Bertram JF, Schad LR, Gretz N, Munoz-Felix JM, Fuentes-Calvo I, Lopez-Novoa JM, Martinez-Salgado C, Kimura T, Takabatake Y, Takahashi A, Kaimori JY, Matsui I, Namba T, Kitamura H, Niimura F, Matsusaka T, Soga T, Rakugi H, Isaka Y, Shin SJ, Kim KS, Kim WK, Rampanelli E, Teske G, Leemans J, Florquin S, Small D, Bennett N, Roy S, Gobe G, Blazquez-Medela AM, Garcia-Sanchez O, Lopez-Hernandez FJ, Lopez-Novoa JM, Martinez-Salgado C, Deibel A, Cheng J, Warner G, Knudsen B, Gray C, Lien K, Juskewitch J, Grande J, Wang N, Wang X, Zeng M, Sun B, Xing C, Zhao X, Xiong M, Yang J, Cao K, Priante G, Musacchio E, Sartori L, Valvason C, Baggio B, Pitlovanciv EDON, Reis LA, Pessoa EA, Teixeira L, Borges FT, Simoes MJ, Schor N, Munoz-Felix JM, Duwel A, Lopez-Novoa JM, Martinez-Salgado C, Doustar Y, Mohajeri D, Smirnov AV, Kucher AG, Ivanova GT, Berseneva ON, Parastaeva MM, Zarajsky MI, Saburova IJ, Kaukov IG, Koppe L, Fouque D, Dugenet Y, Soulage C, Wan J, Yang X, Cui J, Zou Z. Experimental pathology. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.52] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
Tsuge I, Kondo Y, Nakajima Y, Nakagawa N, Imai K, Nonoyama S, Oshima K, Ohara O, Hatanaka M, Kitano E, Kitamura H, Urisu A. Hyper IgM syndrome and complement Clq deficiency in an individual with systemic lupus erythematosus-like disease. Clin Exp Rheumatol 2010; 28:558-560. [PMID: 20810037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2010] [Accepted: 06/25/2010] [Indexed: 05/29/2023]
Abstract
Many immunedeficiency syndromes are associated with autoimmune disorders. We here report on a girl with a systemic lupus erythematosus-like disease who suffered from both hyperimmunoglobulin M syndrome (HIGMS) and C1q deficiency. Despite severe central nervous system-lupus like disease, probably due to C1q deficiency, kidney function was relatively spared. IgM autoantibody might play a protective role against lupus-glomerulonephritis.
Collapse
Affiliation(s)
- I Tsuge
- Department of Paediatrics, Fujita Health University, Aichi, Japan.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|